Total Payments
$5,177
2024 Payments
$386.71
Companies
15
Transactions
62
Medicare Patients
747
Medicare Billing
$70,460
Payment Breakdown by Category
Food & Beverage$4,677 (90.3%)
Consulting$500.00 (9.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,677 | 61 | 90.3% |
| Consulting Fee | $500.00 | 1 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,288 | 22 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $929.47 | 9 | $0 (2017) |
| Allergan Inc. | $730.37 | 6 | $0 (2018) |
| Bausch & Lomb Americas Inc. | $620.03 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $494.69 | 7 | $0 (2019) |
| Oyster Point Pharma, Inc. | $234.01 | 2 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $149.50 | 2 | $0 (2022) |
| Shire North American Group Inc | $132.41 | 1 | $0 (2017) |
| Kowa Pharmaceuticals America, Inc. | $124.98 | 1 | $0 (2022) |
| Alcon Vision LLC | $116.88 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $386.71 | 3 | Bausch & Lomb Americas Inc. ($386.71) |
| 2023 | $367.46 | 5 | Bausch & Lomb Americas Inc. ($233.32) |
| 2022 | $483.97 | 4 | Oyster Point Pharma, Inc. ($234.01) |
| 2021 | $125.00 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($125.00) |
| 2020 | $218.55 | 7 | Bausch & Lomb, a division of Bausch Health US, LLC ($169.74) |
| 2019 | $705.18 | 13 | Bausch & Lomb, a division of Bausch Health US, LLC ($452.97) |
| 2018 | $914.71 | 11 | Bausch & Lomb, a division of Bausch Health US, LLC ($540.05) |
| 2017 | $1,976 | 18 | Valeant Pharmaceuticals North America LLC ($929.47) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 09/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 06/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $136.71 | General |
| Category: Ophthalmology | ||||||
| 10/05/2023 | Alcon Vision LLC | Rocklatan (Drug), Simbrinza, Rhopressa | Food and Beverage | In-kind items and services | $116.88 | General |
| Category: Ophthalmology | ||||||
| 09/19/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $99.99 | General |
| Category: Ophthalmology | ||||||
| 08/03/2023 | Orthofix Medical, Inc. | Physio-Stim (Device), Spinal-Stim | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 07/10/2023 | Bausch & Lomb Americas Inc. | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Ophthalmology | ||||||
| 04/13/2023 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $124.98 | General |
| 12/08/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: DRY EYE | ||||||
| 10/27/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: Pain Management | ||||||
| 06/09/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $114.08 | General |
| Category: DRY EYE | ||||||
| 05/24/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Ophthalmology | ||||||
| 09/09/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 12/23/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), ALREX, LOTEMAX | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/22/2020 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug), BROMSITE, CEQUA | Food and Beverage | Cash or cash equivalent | $24.52 | General |
| Category: Ophthalmology | ||||||
| 11/09/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM, LOTEMAX | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/08/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | BEPREVE (Drug), ALREX, LOTEMAX SM | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/25/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Cardiovascular | ||||||
| 04/07/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM, BEPREVE | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/12/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $116.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/18/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM, BEPREVE | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), ALREX, LOTEMAX SM | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), ALREX, BEPREVE | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/13/2019 | Novartis Pharmaceuticals Corporation | PAZEO (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 163 | 233 | $49,626 | $15,389 |
| 2022 | 4 | 197 | 283 | $63,524 | $19,450 |
| 2021 | 3 | 185 | 241 | $54,116 | $18,041 |
| 2020 | 3 | 202 | 250 | $60,732 | $17,580 |
Total Patients
747
Total Services
1,007
Medicare Billing
$70,460
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 65 | 125 | $25,280 | $7,839 | 31.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 59 | 59 | $16,755 | $5,111 | 30.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 14 | 14 | $4,708 | $1,568 | 33.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 25 | 35 | $2,883 | $871.05 | 30.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 94 | 176 | $35,904 | $11,601 | 32.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 68 | 70 | $20,160 | $6,136 | 30.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 17 | 17 | $5,780 | $1,251 | 21.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 18 | 20 | $1,680 | $462.27 | 27.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 86 | 140 | $28,700 | $9,831 | 34.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 81 | 83 | $23,904 | $7,662 | 32.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 18 | 18 | $1,512 | $548.64 | 36.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 97 | 141 | $28,476 | $8,162 | 28.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 85 | 89 | $25,456 | $7,718 | 30.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 20 | 20 | $6,800 | $1,701 | 25.0% |
About Dr. Michael Rose, MD
Dr. Michael Rose, MD is a Ophthalmology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861593006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Rose, MD has received a total of $5,177 in payments from pharmaceutical and medical device companies, with $386.71 received in 2024. These payments were reported across 62 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,677).
As a Medicare-enrolled provider, Rose has provided services to 747 Medicare beneficiaries, totaling 1,007 services with total Medicare billing of $70,460. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Los Angeles, CA
- Active Since 09/26/2006
- Last Updated 01/16/2014
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861593006
Products in Payments
- MIEBO (Drug) $486.70
- VYZULTA (Drug) $405.35
- PROLENSA (Drug) $405.03
- LUMIGAN (Drug) $249.83
- LOTEMAX SM (Drug) $238.87
- TYRVAYA (Drug) $234.01
- ALREX (Drug) $225.33
- XIIDRA (Drug) $132.41
- LOTEMAX GEL (Drug) $126.86
- RESTASIS (Drug) $125.00
- SIMBRINZA (Biological) $125.00
- Cequa (Drug) $124.98
- Seglentis (Drug) $124.98
- COMBIGAN (Drug) $117.99
- Rocklatan (Drug) $116.88
- Rhopressa (Drug) $113.96
- ENTRESTO (Drug) $106.61
- TRAVATAN Z (Drug) $105.97
- Repatha (Biological) $105.81
- ZYLET (Drug) $99.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Los Angeles
Dr. Andrew Moshfeghi, Md, MD
Ophthalmology — Payments: $898,549
Ophthalmology $898,549
Dr. Barry Seibel, M.d, M.D
Ophthalmology — Payments: $893,403
Ophthalmology $893,403
Neda Shamie, M.d, M.D
Ophthalmology — Payments: $693,812
Ophthalmology $693,812
David Boyer, Md, MD
Ophthalmology — Payments: $514,544
Ophthalmology $514,544
David Hamilton, Od, OD
Ophthalmology — Payments: $477,856
Ophthalmology $477,856
Dr. Nicole Fram, Md, MD
Ophthalmology — Payments: $382,620
Ophthalmology $382,620